# Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions

> **NCT00660166** · PHASE1 · COMPLETED · sponsor: **Tufts Medical Center** · enrollment: 13 (actual)

## Conditions studied

- Lymphoma
- Myeloma
- Leukemia

## Interventions

- **BIOLOGICAL:** NK-Cell Infusion

## Key facts

- **NCT ID:** NCT00660166
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2012-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00660166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00660166, "Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00660166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*